Compare BGS & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BGS | LCTX |
|---|---|---|
| Founded | 1996 | 1990 |
| Country | United States | United States |
| Employees | 86 | N/A |
| Industry | Packaged Foods | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 297.1M | 251.4M |
| IPO Year | 2004 | 1996 |
| Metric | BGS | LCTX |
|---|---|---|
| Price | $2.35 | $1.01 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | $3.60 | ★ $5.50 |
| AVG Volume (30 Days) | ★ 2.0M | 1.4M |
| Earning Date | 11-10-2026 | 11-09-2026 |
| Dividend Yield | ★ 16.81% | N/A |
| EPS Growth | ★ 83.02 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,828,687,000.00 | $14,556,000.00 |
| Revenue This Year | N/A | $4.38 |
| Revenue Next Year | $0.63 | $10.80 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 53.24 |
| 52 Week Low | $1.99 | $0.88 |
| 52 Week High | $6.38 | $2.09 |
| Indicator | BGS | LCTX |
|---|---|---|
| Relative Strength Index (RSI) | 44.63 | 51.56 |
| Support Level | N/A | $0.89 |
| Resistance Level | $3.75 | $1.05 |
| Average True Range (ATR) | 0.11 | 0.06 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 63.16 | 67.61 |
B&G Foods Inc manufactures, sells, and distributes a range of branded, shelf-stable, and frozen food and household products across the United States, Canada, and Puerto Rico. Its products include frozen and canned vegetables, canola and other cooking oils, vegetable shortening, cooking sprays, oatmeal and other hot cereals, fruit spreads, canned meats and beans, bagel chips, spices, seasonings, hot sauces, and wine vinegar. The company's main brands include Crisco, Clabber Girl, Bear Creek, Polaner, Underwood, B&G, Grandma's, New York Style, B&M, Baker's Joy, Regina, TrueNorth, Static Guard, SugarTwin and Brer Rabbit. It operates in four reportable segments: i) Specialty, the majoriy revenue generating segment, ii) Meals, iii) Frozen & Vegetables, iv) Spices & Flavor Solutions.
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.